PDLIM7 and Epstein-Barr virus infection: The administration of live EBV to those reconstituted mice successfully infected the reconstituted human B cells, developed LMP1+ B cell proliferation, and mounted human MHC class I– and class II–restricted adaptive immune responses to EBV infection (38–40).